ESCMID Global

Every patient deserves actionable answers

See the agenda

Here's what we're bringing to ESCMID Global 2026

Empowering confident decisions in infectious disease care means supporting every step of the diagnostic journey. We're here to help you move from sample to actionable results with clarity, precision and confidence.

Visit us at Hall B1, Booth C20 to explore how our diagnostic and research technologies support your day-to-day challenges. Take advantage of our full program of activities, including in-booth expert spotlight sessions, upcoming product features and technology demos.

Our ESCMID Global 2026 program

  • icon-bulbJoin in-booth spotlight sessions

    Join your peers as they share their experience and expertise on current topics in infectious disease diagnostics.

    Location: Hall B1, Booth C20

  • icon-screen-clustVisit our diagnostic innovation areas

    Explore what's new in our focus areas for syndromic testing, TB infection testing and Sample to Insight solutions.

    Location: Hall B1, Booth C20

  • icon-cta-contactGet live technology demos

    See our latest instruments in action, including QIAsymphony® Connect, QIAstat-Dx®, QIAstat-Dx Rise and QIAcuityDx®.

    Location: Hall B1, Booth C20

In-booth spotlight sessions at Hall B1, Booth C20

Sunday, April 19
Time Title Speaker
10:15–10:35 a.m.
Add to calendar		 Improving microbial sequencing with optimized extraction:
Swedish experience		 Lars-Ola Arvidsson
Department of Clinical Microbiology,
Hallands Sjukhus Halmstad, Halmstad,
Region Halland County, Sweden
12:15–12:45 p.m.
Add to calendar		 Early experience
with the QIAstat-Dx BCID Plus AMR Panels
(Performance Evaluation Use Only) 		Laurence Armand-Lefevre, PharmD, PhD
Professor of Microbiology at University of Paris Cité;
Head of the Bacteriology Department at Bichat-Claude Bernard Hospital, France
Monday, April 20
12:15–12:35 p.m.
Add to calendar		 Evaluation of a fully automated
second-generation interferon-gamma release assay
for latent tuberculosis infection:
Diagnostic performance and clinical implications 		Shanthiya Akeesan
Specialist Biomedical Scientist,
South West London Pathology,
London, United Kingdom
3:30–3:50 p.m.
Add to calendar		 Clinical and operational performance of
QuantiFERON-TB Gold Plus: focus on immunocompromised
patients and biologics treatment		 Miguel Santin, PhD
Tuberculosis Unit, Department of Infectious Diseases,
Bellvitge University Hospital-IDIBELL,
L'Hospitalet de Llobregat, Barcelona, Spain

Poster presentations

Meet the speakers

Our infectious disease solutions

Infectious disease portfolio

The technology we're showcasing at ESCMID Global is just the tip of the iceberg. There's so much we have to offer, from sample prep to detection, diagnostic tools to research use tests and bioinformatics. Explore our full infectious disease portfolio.

 

Download the flyer

Syndromic testing with QIAstat-Dx solutions

Accelerate TB insights

Sample to Insight solutions

Our clinical resources

Explore tools from our Medical Affairs team

Find the latest research, videos and publications related to our therapeutic areas. And learn how you can submit a proposal for an investigator-initiated study.

Learn more
Investigator Initiated Studies

Expert perspectives
–
Watch on-demand clinical webinars

QIAstat-Dx and QuantiFERON-TB Gold Plus are for in vitro diagnostic use.

QIAseq NGS technologies and the QIAseq xHYB Mycobacterium tuberculosis Panel are for research use only. These products are not intended for diagnostic use.

For up-to-date licensing information and product-specific disclaimers, see the respective QIAGEN kit instructions for use or user manual. QIAGEN instructions for use and user manuals are available at www.qiagen.com or can be requested from QIAGEN Technical Services (or your local distributor).